Hemenway Trust Hemenway Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,183
| Closed | -$277K | – | 144 |
|
|
2017
Q4 | $277K | Sell |
2,183
-615
| -22% | -$78K | 0.05% | 128 |
|
|
2017
Q3 | $329K | Sell |
2,798
-150
| -5% | -$17.6K | 0.07% | 99 |
|
|
2017
Q2 | $235K | Buy |
+2,948
| New | +$235K | 0.05% | 118 |
|
|
2017
Q1 | – | Sell |
-16,773
| Closed | -$628K | – | 130 |
|
|
2016
Q4 | $628K | Buy |
16,773
+3,373
| +25% | +$126K | 0.16% | 75 |
|
|
2016
Q3 | $908K | Buy |
13,400
+200
| +2% | +$13.6K | 0.23% | 68 |
|
|
2016
Q2 | $732K | Buy |
13,200
+525
| +4% | +$29.1K | 0.19% | 71 |
|
|
2016
Q1 | $796K | Buy |
12,675
+150
| +1% | +$9.42K | 0.21% | 67 |
|
|
2015
Q4 | $1.18M | Hold |
12,525
| – | – | 0.31% | 59 |
|
|
2015
Q3 | $1.01M | Buy |
12,525
+245
| +2% | +$19.7K | 0.28% | 64 |
|
|
2015
Q2 | $1.47M | Buy |
12,280
+150
| +1% | +$18K | 0.38% | 55 |
|
|
2015
Q1 | $1.27M | Buy |
12,130
+60
| +0.5% | +$6.27K | 0.33% | 57 |
|
|
2014
Q4 | $1.17M | Buy |
12,070
+40
| +0.3% | +$3.88K | 0.35% | 58 |
|
|
2014
Q3 | $940K | Buy |
12,030
+30
| +0.3% | +$2.34K | 0.29% | 61 |
|
|
2014
Q2 | $758K | Hold |
12,000
| – | – | 0.23% | 68 |
|
|
2014
Q1 | $806K | Sell |
12,000
-12,000
| -50% | -$806K | 0.25% | 63 |
|
|
2013
Q4 | $1.54M | Sell |
24,000
-6,000
| -20% | -$386K | 0.49% | 53 |
|
|
2013
Q3 | $1.92M | Hold |
30,000
| – | – | 0.72% | 46 |
|
|
2013
Q2 | $930K | Buy |
+30,000
| New | +$930K | 0.4% | 52 |
|